ALERS Eurobio Scientific Société anonyme

EPA · FR · Healthcare · Medical Devices · eurobio-scientific.com

25.20EUR+0.40%Mkt Cap: 275.78M $P/E: 36.00Today

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The compan…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap275.78M USD

Enterprise Value262.08M USD

Revenue (TTM)187.24M USD

Gross Profit83.53M USD

Net Income (TTM)5.29M USD

Revenue/Share16.81 EUR

Last Price25.20 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees443

CountryFR

SectorHealthcare

IndustryMedical Devices

ISINFR0013240934

Valuation

P/E (Trailing)36.00

P/E (Forward)22.21

PEG—

EV/EBITDA10.58

EV/Revenue1.40

P/S1.47

P/B1.32

EPS (TTM)0.70

EPS (Forward)1.13

52W Range

19.2095% of range25.50

52W High25.50 EUR

52W Low19.20 EUR

Profitability

Gross Margin45.58%

Oper. Margin10.02%

EBITDA Margin13.23%

Profit Margin2.89%

ROE2.65%

ROA1.89%

Growth

Revenue Growth4.50%

Earnings Growth99.00%

Cash Flow & Leverage

Operating CF20.49M USD

CapEx (TTM)13.66M USD

FCF Margin-7.42%

FCF Yield-5.03%

Net Debt-12.61M USD

Net Debt/EBITDA-0.51

Balance Sheet

Debt/Equity0.09

Current Ratio3.16

Quick Ratio1.84

Book Value/Sh19.01 EUR

Cash/Share2.62 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateSep 1, 2017

Analyst Consensus

Rating—

Target (Mean)30.00 EUR

Upside (mean)+19.0%

Target Range30.00 EUR – 30.00 EUR

# Analysts1

Ownership

Shares Out.10.07M

Float843.62K

Insiders0.00%

Institutions88.27%

Technical

SMA 5021.56 (+16.9%)

SMA 20022.47 (+12.2%)

Beta0.70

S&P 52W Chg14.58%

Avg Vol (30d)6.25K

Avg Vol (10d)6.53K

Technical Indicators

RSI (14)76.6

MACD1.2613

MACD Signal1.1266

MACD Hist.+0.1347

BB Upper28.29 EUR

BB Middle23.05 EUR

BB Lower17.81 EUR

BB Width45.45%

ATR (14)0.4991 EUR

Vol Ratio (20d)1.00x